Clinical Trials Logo

Clinical Trial Summary

Aging-related cognitive decline may be affected by brain cholesterol and the health of cell membranes. Certain nutritional supplements have been proposed to support membrane health, and there is increasing interest in plasmalogens and Omega-3 derived oil supplements to support brain health among older adults. Plasmalogens are compounds found in neural cell membranes that are connected to cholesterol processing. Neural cells that have low plasmalogens have shown an inability to process cholesterol properly. Recent research suggests that abnormalities in cholesterol processing and low levels of plasmalogen may play a role in age-related cognitive decline. The product being investigated in this study is the ProdromeNeuro Omega 3 oil nutritional supplement. This product contains naturally occurring fatty acids in higher concentrations than similar products that are commercially available. The purpose of this research study is to better understand the effects of ProdromeNeuro Omega-3 nutritional supplementation among participants with age-related cognitive decline. It is hoped that taking this product over the course of 4 months will result in improved plasmalogen levels, brain connectivity seen on advanced brain imaging, as well as improved cognitive assessment measurements.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05041088
Study type Interventional
Source Neurological Associates of West Los Angeles
Contact Maggie Zielinski, BS
Phone 3108295968
Email mzielinski@theneuroassociates.com
Status Not yet recruiting
Phase Phase 1
Start date June 20, 2023
Completion date November 20, 2023